{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:28:44Z","timestamp":1792801724490,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Selcuk University Scientific Research Projects","award":["24401205"],"award-info":[{"award-number":["24401205"]}],"id":[{"id":"https:\/\/ror.org\/045hgzm75","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-01071-2","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T07:13:40Z","timestamp":1766214820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multi-target antidiabetic therapy with voglibose, ubiquinone, and tempol: synergistic effects on liver and skeletal muscle in experimental type 2 diabetes"],"prefix":"10.1186","volume":"27","author":[{"given":"\u00d6znur Tufan","family":"Akarslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dudu Erko\u00e7","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed Bahaeddin","family":"D\u00f6rtbudak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fc\u015fra","family":"Kilin\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130brahim","family":"B\u00fcy\u00fckta\u015fkapulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"G\u00f6kt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Demircio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"Er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Dik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"issue":"1","key":"1071_CR1","first-page":"107","volume":"10","author":"KM Abdul","year":"2020","unstructured":"Abdul KM, Hashim MJ, King JK, Govender RD, Mustafa H, Kaabi AJ. Epidemiology of type 2 diabetes\u2014global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10(1):107\u201311.","journal-title":"J Epidemiol Glob Health"},{"key":"1071_CR2","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.jcjd.2017.10.003","volume":"42","author":"Z Punthakee","year":"2018","unstructured":"Punthakee Z, Goldenberg R, Katz P. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes. 2018;42:S10\u20135.","journal-title":"Can J Diabetes"},{"issue":"11","key":"1071_CR3","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.mpmed.2010.08.007","volume":"38","author":"NG Forouhi","year":"2010","unstructured":"Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine. 2010;38(11):602\u20136.","journal-title":"Medicine"},{"key":"1071_CR4","unstructured":"IDF. International Diabetes Federation (IDF) diabetes atlas 2025. In. Brussels; 2019."},{"issue":"11","key":"1071_CR5","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/jpp\/rgae100","volume":"76","author":"B Dik","year":"2024","unstructured":"Dik B, Parlak TM, Ates MB, Tufan O. Exploring the combined therapeutic efficacy of bexarotene and Icariin in type 2 diabetic rats. J Pharm Pharmacol. 2024;76(11):1474\u201381.","journal-title":"J Pharm Pharmacol"},{"key":"1071_CR6","doi-asserted-by":"crossref","unstructured":"Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018.","DOI":"10.1152\/physrev.00063.2017"},{"issue":"1","key":"1071_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/JCI77812","volume":"126","author":"VT Samuel","year":"2016","unstructured":"Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016;126(1):12\u201322.","journal-title":"J Clin Invest"},{"issue":"4","key":"1071_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2337\/db09-9028","volume":"58","author":"RA DeFronzo","year":"2009","unstructured":"DeFronzo RA. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773\u201395.","journal-title":"Diabetes"},{"issue":"3","key":"1071_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/fcp.12975","volume":"38","author":"Y Korkmaz","year":"2024","unstructured":"Korkmaz Y, Dik B. The comparison of the antidiabetic effects of exenatide, empagliflozin, quercetin, and combination of the drugs in type 2 diabetic rats. Fundam Clin Pharmacol. 2024;38(3):511\u201322.","journal-title":"Fundam Clin Pharmacol"},{"key":"1071_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11684-019-0729-1","volume":"14","author":"P Zhang","year":"2020","unstructured":"Zhang P, Li T, Wu X, Nice EC, Huang C, Zhang Y. Oxidative stress and diabetes: antioxidative strategies. Front Med. 2020;14:583\u2013600.","journal-title":"Front Med"},{"issue":"8","key":"1071_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1139\/cjpp-2017-0769","volume":"96","author":"B Dik","year":"2018","unstructured":"Dik B, Bahcivan E, Eser Faki H, Uney K. Combined treatment with interleukin-1 and tumor necrosis factor-alpha antagonists improve type 2 diabetes in rats. Can J Physiol Pharmacol. 2018;96(8):751\u20136.","journal-title":"Can J Physiol Pharmacol"},{"issue":"10085","key":"1071_CR12","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","volume":"389","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239\u201351.","journal-title":"Lancet"},{"issue":"8","key":"1071_CR13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1517\/14656566.2014.918956","volume":"15","author":"K Kaku","year":"2014","unstructured":"Kaku K. Efficacy of Voglibose in type 2 diabetes. Expert Opin Pharmacother. 2014;15(8):1181\u201390.","journal-title":"Expert Opin Pharmacother"},{"issue":"12","key":"1071_CR14","first-page":"3023","volume":"7","author":"AS Dabhi","year":"2013","unstructured":"Dabhi AS, Bhatt NR, Shah MJ. Voglibose: an alpha glucosidase inhibitor. J Clin Diagn Res. 2013;7(12):3023.","journal-title":"J Clin Diagn Res"},{"key":"1071_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejphar.2014.02.004","volume":"729","author":"RB Jones","year":"2014","unstructured":"Jones RB, Vickers SP, Cheetham SC, Headland KR, Mark M, Klein T. Effect of linagliptin, alone and in combination with Voglibose or exendin-4, on glucose control in male ZDF rats. Eur J Pharmacol. 2014;729:59\u201366.","journal-title":"Eur J Pharmacol"},{"key":"1071_CR16","doi-asserted-by":"publisher","first-page":"118155","DOI":"10.1016\/j.lfs.2020.118155","volume":"258","author":"RA Maheshwari","year":"2020","unstructured":"Maheshwari RA, Parmar GR, Hinsu D, Seth AK, Balaraman R. Novel therapeutic intervention of coenzyme Q10 and its combination with Pioglitazone on the mRNA expression level of adipocytokines in diabetic rats. Life Sci. 2020;258:118155.","journal-title":"Life Sci"},{"issue":"1","key":"1071_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/antiox12010123","volume":"12","author":"O-OP Akpoveso","year":"2023","unstructured":"Akpoveso O-OP, Ubah EE, Obasanmi G. Antioxidant phytochemicals as potential therapy for diabetic complications. Antioxidants. 2023;12(1):123.","journal-title":"Antioxidants"},{"issue":"1","key":"1071_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0891-5849(02)01193-0","volume":"34","author":"JB Mitchell","year":"2003","unstructured":"Mitchell JB, Xavier S, DeLuca AM, Sowers AL, Cook JA, Krishna MC, Hahn SM, Russo A. A low molecular weight antioxidant decreases weight and lowers tumor incidence. Free Radic Biol Med. 2003;34(1):93\u2013102.","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"1071_CR19","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.2337\/diabetes.54.7.2219","volume":"54","author":"AA Banday","year":"2005","unstructured":"Banday AA, Marwaha A, Tallam LS, Lokhandwala MF. Tempol reduces oxidative stress, improves insulin sensitivity, decreases renal dopamine D1 receptor hyperphosphorylation, and restores D1 receptor\u2013G-protein coupling and function in obese Zucker rats. Diabetes. 2005;54(7):2219\u201326.","journal-title":"Diabetes"},{"issue":"4","key":"1071_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/10408390902773037","volume":"50","author":"I Pravst","year":"2010","unstructured":"Pravst I, \u017dmitek K, \u017dmitek J. Coenzyme Q10 contents in foods and fortification strategies. Crit Rev Food Sci Nutr. 2010;50(4):269\u201380.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1071_CR21","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.mito.2007.03.009","volume":"7","author":"G Lenaz","year":"2007","unstructured":"Lenaz G, Fato R, Formiggini G, Genova ML. The role of coenzyme Q in mitochondrial electron transport. Mitochondrion. 2007;7:S8\u201333.","journal-title":"Mitochondrion"},{"issue":"1\u20134","key":"1071_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/biof.5520320121","volume":"32","author":"C Schmelzer","year":"2008","unstructured":"Schmelzer C, Lindner I, Rimbach G, Niklowitz P, Menke T, D\u00f6ring F. Functions of coenzyme Q10 in inflammation and gene expression. BioFactors. 2008;32(1\u20134):179\u201383.","journal-title":"BioFactors"},{"issue":"11","key":"1071_CR23","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1097\/00007611-200111000-00015","volume":"94","author":"BE Burke","year":"2001","unstructured":"Burke BE, Neuenschwander R, Olson RD. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. South Med J. 2001;94(11):1112\u20137.","journal-title":"South Med J"},{"issue":"2","key":"1071_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3904\/kjim.2017.004","volume":"34","author":"IO Sun","year":"2017","unstructured":"Sun IO, Jin L, Jin J, Lim SW, Chung BH, Yang CW. The effects of addition of coenzyme Q10 to Metformin on sirolimus-induced diabetes mellitus. Korean J Intern Med. 2017;34(2):365.","journal-title":"Korean J Intern Med"},{"issue":"2","key":"1071_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/jdi.12135","volume":"5","author":"H Sugihara","year":"2014","unstructured":"Sugihara H, Nagao M, Harada T, Nakajima Y, Tanimura-Inagaki K, Okajima F, Tamura H, Inazawa T, Otonari T, Kawakami M. Comparison of three \u03b1\u2010glucosidase inhibitors for glycemic control and bodyweight reduction in J apanese patients with obese type 2 diabetes. J Diabetes Investig. 2014;5(2):206\u201312.","journal-title":"J Diabetes Investig"},{"issue":"4","key":"1071_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","volume":"52","author":"K Srinivasan","year":"2005","unstructured":"Srinivasan K, Viswanad B, Asrat L, Kaul C, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and Pharmacological screening. Pharmacol Res. 2005;52(4):313\u201320.","journal-title":"Pharmacol Res"},{"issue":"2","key":"1071_CR27","doi-asserted-by":"publisher","first-page":"e89169","DOI":"10.1371\/journal.pone.0089169","volume":"9","author":"MM Amin","year":"2014","unstructured":"Amin MM, Asaad GF, Abdel Salam RM, El-Abhar HS, Arbid MS. Novel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant\/diabetic rats. PLoS ONE. 2014;9(2):e89169.","journal-title":"PLoS ONE"},{"issue":"1","key":"1071_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.17795\/ajmb-31043","volume":"4","author":"S Shahidi","year":"2016","unstructured":"Shahidi S, Jabbarpour Z, Saidijam M, Esmaeili R, Komaki A, Firouzi NH. The effects of the synthetic antioxidant, tempol, on serum glucose and lipid profile of diabetic and non-diabetic rats. Avicenna J Med Biochem. 2016;4(1):2\u201331043.","journal-title":"Avicenna J Med Biochem"},{"issue":"6","key":"1071_CR29","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1995-7645(11)60129-6","volume":"4","author":"S Ohadoma","year":"2011","unstructured":"Ohadoma S, Michael H. Effects of co\u2014administration of methanol leaf extract of catharanthus roseus on the hypoglycemic activity of Metformin and Glibenclamide in rats. Asian Pac J Trop Med. 2011;4(6):475\u20137.","journal-title":"Asian Pac J Trop Med"},{"key":"1071_CR30","doi-asserted-by":"crossref","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2009\u2013\u2009\u2206\u2206CT method. Methods. 2001;25(4):402\u20138.","DOI":"10.1006\/meth.2001.1262"},{"issue":"4","key":"1071_CR31","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3390\/life15040564","volume":"15","author":"MB D\u00f6rtbudak","year":"2025","unstructured":"D\u00f6rtbudak MB, Demircio\u011flu M, Demircio\u011flu \u0130, Nicotra M, Di Cerbo A. Pathological investigation of the effect of bovine colostrum against 5-FU-Induced Liver, Kidney, and heart toxicity in rats. Life. 2025;15(4):564.","journal-title":"Life"},{"issue":"6","key":"1071_CR32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1742-7843.2008.00321.x","volume":"103","author":"A Tahara","year":"2008","unstructured":"Tahara A, Matsuyama-Yokono A, Nakano R, Someya Y, Shibasaki M. Hypoglycaemic effects of antidiabetic drugs in streptozotocin\u2010nicotinamide\u2010induced mildly diabetic and streptozotocin\u2010induced severely diabetic rats. Basic Clin Pharmacol Toxicol. 2008;103(6):560\u20138.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"1071_CR33","first-page":"1078","volume":"41","author":"KQ He","year":"2018","unstructured":"He KQ, Li WZ, Chai XQ, Yin YY, Jiang Y, Li WP. Astragaloside IV prevents kidney injury caused by iatrogenic hyperinsulinemia in a streptozotocin-induced diabetic rat model. Int J Mol Med. 2018;41(2):1078\u201388.","journal-title":"Int J Mol Med"},{"issue":"2","key":"1071_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.nutres.2007.12.005","volume":"28","author":"CM Sena","year":"2008","unstructured":"Sena CM, Nunes E, Gomes A, Santos MS, Proen\u00e7a T, Martins MI, Sei\u00e7a RM. Supplementation of coenzyme Q10 and \u03b1-tocopherol lowers glycated hemoglobin level and lipid peroxidation in pancreas of diabetic rats. Nutr Res. 2008;28(2):113\u201321.","journal-title":"Nutr Res"},{"issue":"1","key":"1071_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1017\/S0007114518001241","volume":"120","author":"CH Yen","year":"2018","unstructured":"Yen CH, Chu YJ, Lee BJ, Lin YC, Lin PT. Effect of liquid ubiquinol supplementation on glucose, lipids and antioxidant capacity in type 2 diabetes patients: a double-blind, randomised, placebo-controlled trial. Br J Nutr. 2018;120(1):57\u201363.","journal-title":"Br J Nutr"},{"issue":"7","key":"1071_CR36","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1017\/S0007114515005528","volume":"115","author":"C Coudray","year":"2016","unstructured":"Coudray C, Fouret G, Lambert K, Ferreri C, Rieusset J, Blachnio-Zabielska A, et al. A mitochondrial-targeted ubiquinone modulates muscle lipid profile and improves mitochondrial respiration in obesogenic diet-fed rats. Br J Nutr. 2016;115(7):1155\u201366.","journal-title":"Br J Nutr"},{"issue":"9","key":"1071_CR37","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nrd3757","volume":"11","author":"R Coppari","year":"2012","unstructured":"Coppari R, Bj\u00f8rb\u00e6k C. Leptin revisited: its mechanism of action and potential for treating diabetes. Nat Rev Drug Discov. 2012;11(9):692\u2013708.","journal-title":"Nat Rev Drug Discov"},{"issue":"35","key":"1071_CR38","doi-asserted-by":"publisher","first-page":"14670","DOI":"10.1073\/pnas.1107163108","volume":"108","author":"BP Cummings","year":"2011","unstructured":"Cummings BP, Bettaieb A, Graham JL, Stanhope KL, Dill R, Morton GJ, Haj FG, Havel PJ. Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCD-T2DM rats. Proc Natl Acad Sci U S A. 2011;108(35):14670\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1071_CR39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.phrs.2005.01.007","volume":"51","author":"J Beltowski","year":"2005","unstructured":"Beltowski J, Jamroz-Wi\u015bniewska A, Borkowska E, W\u00f3jcicka G. Differential effect of antioxidant treatment on plasma and tissue paraoxonase activity in hyperleptinemic rats. Pharmacol Res. 2005;51(6):523\u201332.","journal-title":"Pharmacol Res"},{"key":"1071_CR40","unstructured":"Fadil TA, Khalaf BH, Hussein KI, Hussain SA. Effects of glibenclamide, metformin or their combination on the correlation between serum leptin levels with glycemic control and insulin levels in type 2 DM. 2010."},{"key":"1071_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cbi.2015.12.012","volume":"244","author":"N Maithilikarpagaselvi","year":"2016","unstructured":"Maithilikarpagaselvi N, Sridhar MG, Swaminathan RP, Zachariah B. Curcumin prevents inflammatory response, oxidative stress and insulin resistance in high Fructose fed male Wistar rats: potential role of Serine kinases. Chem Biol Interact. 2016;244:187\u201394.","journal-title":"Chem Biol Interact"},{"issue":"6","key":"1071_CR42","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1159\/000088261","volume":"42","author":"H Dominguez","year":"2005","unstructured":"Dominguez H, Storgaard H, Rask-Madsen C, Steffen HT, Ihlemann N, Baunbjerg ND, et al. Metabolic and vascular effects of tumor necrosis factor-\u03b1 Blockade with etanercept in obese patients with type 2 diabetes. J Vasc Res. 2005;42(6):517\u201325.","journal-title":"J Vasc Res"},{"key":"1071_CR43","first-page":"15158","volume":"30","author":"S Desai","year":"2017","unstructured":"Desai S, Walvekar M, Shaikh N. Cytoprotective effects of lepidium sativum seed extract on liver and pancreas of HFD\/STZ induced type 2 diabetic mice. Diabetes. 2017;30:15158.","journal-title":"Diabetes"},{"issue":"1","key":"1071_CR44","first-page":"120645","volume":"2012","author":"M Haligur","year":"2012","unstructured":"Haligur M, Topsakal S, Ozmen O. Early degenerative effects of diabetes mellitus on pancreas, liver, and kidney in rats: an immunohistochemical study. J Diabetes Res. 2012;2012(1):120645.","journal-title":"J Diabetes Res"},{"issue":"3","key":"1071_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/diabetology4030032","volume":"4","author":"R Gudoor","year":"2023","unstructured":"Gudoor R, Suits A, Shubrook JH. Perfecting the puzzle of pathophysiology: exploring combination therapy in the treatment of type 2 diabetes. Diabetology. 2023;4(3):379\u201392.","journal-title":"Diabetology"},{"key":"1071_CR46","doi-asserted-by":"publisher","first-page":"1301093","DOI":"10.3389\/fendo.2023.1301093","volume":"14","author":"X Xie","year":"2023","unstructured":"Xie X, Wu C, Hao Y, Wang T, Yang Y, Cai P, et al. Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review. Front Endocrinol. 2023;14:1301093.","journal-title":"Front Endocrinol"},{"issue":"3","key":"1071_CR47","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.yrtph.2006.05.006","volume":"45","author":"JN Hathcock","year":"2006","unstructured":"Hathcock JN, Shao A. Risk assessment for coenzyme Q10 (Ubiquinone). Regul Toxicol Pharmacol. 2006;45(3):282\u20138.","journal-title":"Regul Toxicol Pharmacol"},{"key":"1071_CR48","doi-asserted-by":"crossref","unstructured":"Hossain M, Suchi TT, Samiha F, Islam MM, Tully FA, Hasan J, et al. Coenzyme Q10 ameliorates carbofuran induced hepatotoxicity and nephrotoxicity in Wister rats. Heliyon. 2023; 9(2).","DOI":"10.1016\/j.heliyon.2023.e13727"},{"issue":"2","key":"1071_CR49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000443414","volume":"41","author":"G Zhang","year":"2016","unstructured":"Zhang G, Wang Q, Zhou Q, Wang R, Xu M, Wang H, et al. Protective effect of tempol on acute kidney injury through PI3K\/Akt\/Nrf2 signaling pathway. Kidney Blood Press Res. 2016;41(2):129\u201338.","journal-title":"Kidney Blood Press Res"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-01071-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01071-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01071-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T16:03:16Z","timestamp":1769443396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-025-01071-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1071"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-01071-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6782451\/v1","asserted-by":"object"}]},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. The research protocol was reviewed and approved by the Ethics Committee of Selcuk University Chair of Experimental Medicine Research and Application Center (Ethical approval number 2024-28). All procedures conformed to the EU Directive 2010\/63\/EU and institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statements"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}